Yoichi Nakamura
Overview
Explore the profile of Yoichi Nakamura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
232
Citations
1853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Natsuyama Y, Shimada K, Nakamura Y, Kawata S, Yakura T, Li Z, et al.
Folia Morphol (Warsz)
. 2024 Nov;
PMID: 39573975
Background: Marsupials have a narrower range of forelimb morphological features than placental mammals. It is hypothesized that this is due to a constraint in the reproductive biology of marsupials. The...
2.
Funaita C, Furuie W, Koike F, Oyama S, Endo J, Otani Y, et al.
Sci Rep
. 2023 Dec;
13(1):21608.
PMID: 38062060
No official clinical reference values have been established for MostGraph, which measures total respiratory resistance and reactance using the forced oscillation technique, complicating result interpretation. This study aimed to establish...
3.
Nakamura Y, Furukawa S
World J Diabetes
. 2023 Nov;
14(10):1562-1572.
PMID: 37970135
Background: The continuous glucose monitoring (CGM) system has become a popular evaluation tool for glucose fluctuation, providing a detailed description of glucose change patterns. We hypothesized that glucose fluctuations may...
4.
Takano-Kawabe K, Matoba K, Nakamura Y, Moriyama M
Neurochem Res
. 2023 Sep;
49(1):199-211.
PMID: 37702891
Activation of glial cells, astrocytes and microglia, has been observed in neurodegenerative diseases including Alzheimer's disease (AD). Amyloid β (Aβ), which is aggregated and the aggregation is detected as characteristic...
5.
Kasai T, Mori K, Nakamura Y, Seki N, Ichikawa Y, Saito H, et al.
Cancer Med
. 2023 May;
12(14):14988-14999.
PMID: 37226421
Introduction: Cisplatin plus pemetrexed followed by pemetrexed is an efficacious platinum combination regimen for advanced non-squamous, non-small cell lung cancer (NSCLC). Data regarding the addition of bevacizumab, especially in maintenance...
6.
Niimi A, Fukunaga K, Taniguchi M, Nakamura Y, Tagaya E, Horiguchi T, et al.
Allergol Int
. 2023 Mar;
72(2):207-226.
PMID: 36959028
Asthma is characterized by chronic airway inflammation, variable airway narrowing, and sensory nerve irritation, which manifest as wheezing, dyspnea, chest tightness, and cough. Longstanding asthma may result in airway remodeling...
7.
Nagayama K, Fukutomi Y, Nakatani E, Hamada Y, Irie M, Azekawa K, et al.
Allergol Int
. 2022 Nov;
72(2):245-251.
PMID: 36443222
Background: Information on changes in asthma prevalence and the treatment status for asthma is used as basic information for taking medical and administrative measures against asthma. However, this information among...
8.
Hibino M, Hiranuma O, Takemura Y, Katayama Y, Chihara Y, Harada T, et al.
JTO Clin Res Rep
. 2022 Nov;
3(12):100424.
PMID: 36438852
Introduction: First-line treatment of -mutated NSCLC with erlotinib plus antiangiogenic inhibitor exhibits promising results. However, the efficacy of this combination has not been fully investigated. Therefore, we evaluated the efficacy...
9.
Uda S, Yamada T, Yoshimura A, Goto Y, Yoshimine K, Nakamura Y, et al.
Transl Lung Cancer Res
. 2022 Oct;
11(9):1847-1857.
PMID: 36248326
Background: Topoisomerase is an essential enzyme for deoxyribonucleic acid replication, and its inhibitors suppress tumor progression. Amrubicin, a topoisomerase II inhibitor, is mainly used in the second-line treatment of patients...
10.
Kasai T, Mori K, Sugiyama T, Koyama N, Nakamura Y, Ohyanagi F, et al.
Int J Clin Oncol
. 2022 Oct;
27(12):1841-1848.
PMID: 36241930
Background: Nedaplatin and nab-paclitaxel are each efficacious in the treatment of squamous cell lung cancer. Patients And Methods: Eligibility criteria were: no prior chemotherapy, advanced squamous cell lung cancer; performance...